News

Clinical & Regulatory,Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Therapeutic Areas
EURneffy recommended for emergency anaphylaxis treatment in NHS Wales
read more
Biotech & Pharma Business,Digital & Data,Research & Development
Lifebit awarded three-year NIHR BioResource research environment contract
read more
Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics
Resolution Therapeutics partners with Blood Centers of America for RTX001 programme
read more
Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Researchers develop human iPS cell model of heart failure
read more
Advanced Therapies,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Resolution Therapeutics completes Phase 1/2 RTX001 liver disease trial dosing
read more
Advanced Therapies,Biotech & Pharma Business,Pharmaceuticals and therapeutics,Research & Development
Eleva separates biologics platform from Factor H therapy
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
ENA Respiratory begins Phase 2a dosing of nasal antiviral INNA-051
read more
Advanced Therapies,Biotech & Pharma Business,Research & Development
Circio raises NOK 200M (€18.6M) to advance in vivo CAR-T programme
read more
Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
AstraZeneca advances oral COPD drug into Phase 2b trial
read more
Biotech & Pharma Business,Manufacturing & Supply Chain,Medical devices,Research & Development
Fuse Diagnostics raises £1M to scale rapid molecular testing platform
read more
Central Nervous System,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Amyl Therapeutics raises €8.25M to advance pan-amyloid neurodegenerative disease platform
read more
Clinical & Regulatory,Digital & Data,Research & Development
CluePoints brings AI-powered clinical data review to DPHARM 2026
read more
Digital & Data,Drug Discovery & Development,Research & Development
NVision deploys quantum-enhanced MRI platform at Hokkaido University
read more
Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
L-glutamine shows 44% response rate in Phase 1 pancreatic cancer trial
read more
Digital & Data,Manufacturing & Supply Chain
Systech launches AI-assisted pharmaceutical traceability platform
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
Karyopharm seeks FDA accelerated approval for selinexor in myelofibrosis
read more

EURneffy recommended for emergency anaphylaxis treatment in NHS Wales

Lifebit awarded three-year NIHR BioResource research environment contract

Resolution Therapeutics partners with Blood Centers of America for RTX001 programme

Researchers develop human iPS cell model of heart failure

Resolution Therapeutics completes Phase 1/2 RTX001 liver disease trial dosing

Eleva separates biologics platform from Factor H therapy

ENA Respiratory begins Phase 2a dosing of nasal antiviral INNA-051

Circio raises NOK 200M (€18.6M) to advance in vivo CAR-T programme

AstraZeneca advances oral COPD drug into Phase 2b trial

Fuse Diagnostics raises £1M to scale rapid molecular testing platform

Amyl Therapeutics raises €8.25M to advance pan-amyloid neurodegenerative disease platform

CluePoints brings AI-powered clinical data review to DPHARM 2026

NVision deploys quantum-enhanced MRI platform at Hokkaido University

L-glutamine shows 44% response rate in Phase 1 pancreatic cancer trial

Systech launches AI-assisted pharmaceutical traceability platform

Karyopharm seeks FDA accelerated approval for selinexor in myelofibrosis

main menu

recent posts

Novadip secures €10.4M to advance pivotal Phase 3 trial

Telix to acquire ITM in $1.65BN radiopharmaceutical deal

Andelyn to manufacture FDA-approved Fayuvi gene therapy for Sanfilippo syndrome

get connected